DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Clamp AR, James EC, McNeish IA. et al.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet 2019;
394: 2084-2095
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.